Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 3 (2006), Issue 5 (May)

1. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
   J Clin Oncol, 24(13): 2059-64. [Abstract] [Full-text]
2. Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer.
   J Am Coll Surg, 202(5): 732-6. [Abstract] [Full-text]
3. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
   Am J Surg, 191(5): 665-8. [Abstract] [Full-text]
4. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
   Biochem Pharmacol, 71(11): 1540-50. [Abstract] [Full-text]
5. Completion of therapy by Medicare patients with stage III colon cancer.
   J Natl Cancer Inst, 98(9): 610-9. [Abstract] [Full-text]
6. Early prediction of anastomotic leak in colorectal cancer surgery by intramucosal pH.
   Dis Colon Rectum, 49(5): 595-601. [Abstract] [Full-text]
7. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
   Dis Colon Rectum, 49(5): 609-15. [Abstract] [Full-text]
8. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy.
   Int J Radiat Oncol Biol Phys, 65(2): 445-51. [Abstract] [Full-text]
9. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells.
   Cell Signal, 18(8): 1262-9. [Abstract] [Full-text]
10. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).
    Gynecol Oncol, 101(2): 261-8. [Abstract] [Full-text]
11. ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.
    Biochem Biophys Res Commun, 345(1): 216-21. [Abstract] [Full-text]
12. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.
    J Clin Oncol, 24(15): 2368-75. [Abstract] [Full-text]
13. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    J Surg Oncol, 93(7): 523-8. [Abstract] [Full-text]
14. Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease.
    Cancer Immunol Immunother, 55(9): 1043-51. [Abstract] [Full-text]
15. Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated.
    Cancer Immunol Immunother, 55(9): 1081-90. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.